News Opthea Limited

Equities

OPT

AU000000OPT2

Market Closed - Australian S.E. Other stock markets 11:40:06 26/06/2024 am IST			5-day change	1st Jan Change
0.36 ^AUD	+4.35%		-2.70%	-36.84%

14/06	Opthea Raises AU$171.5 Million via Institutional Placement, Offer; Shares Down 23%	MT
12/06	Opthea to Raise $150.4 Million Through Placement, Entitlement Offers	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens	19/06	AQ
Opthea Raises AU$171.5 Million via Institutional Placement, Offer; Shares Down 23%	14/06	MT
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)	14/06	AQ
Rights Issue: 100 new shares @ 0.4 AUD for 122 existing shares	14/06	FA
Opthea to Raise $150.4 Million Through Placement, Entitlement Offers	12/06	MT
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)	12/06	AQ
Opthea To Present at Clinical Trials at the Summit Meeting	03/06	AQ
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD	28/05	AQ
Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD	28/05	CI
Opthea Completes Enrollments in COAST, ShORe Trials	28/05	MT
Opthea Announces Upcoming Presentations at the Retina World Congress 2024	01/05	AQ
Opthea : Quarterly Activity Report - Form 6-K	30/04	PU
Opthea to Present at the OIS Retina Innovation Summit at ARVO	25/04	AQ
Opthea : to Present at the OIS Retina Innovation Summit at ARVO - Form 6-K	25/04	PU
Opthea Appoints John Han, PharmD, as VP Medical Affairs	09/04	AQ
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference	05/04	AQ
Opthea Appoints Sujal Shah to the Board of Directors	04/04	AQ
Opthea Limited Announces Board Changes	04/04	CI
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024	19/03	AQ
Opthea to Participate in the Leerink Partners Global Biopharma Conference	06/03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Opthea Limited

Equities

OPT

AU000000OPT2

Summary

Filters